-
1
-
-
33750949551
-
Treatment decisionmaking for older patients with high-risk myelodysplastic syndrome or acute myeloid leukemia: Problems and approaches
-
Deschler, B., de Witte, T., Mertelsmann, R. & Lubbert, M. Treatment decisionmaking for older patients with high-risk myelodysplastic syndrome or acute myeloid leukemia: problems and approaches. Haematologica 91, 1513-1522 (2006).
-
(2006)
Haematologica
, vol.91
, pp. 1513-1522
-
-
Deschler, B.1
De Witte, T.2
Mertelsmann, R.3
Lubbert, M.4
-
2
-
-
33750530369
-
Acute myeloid leukemia: Epidemiology and etiology
-
Deschler, B. & Lubbert, M. Acute myeloid leukemia: epidemiology and etiology. Cancer 107, 2099-2107 (2006).
-
(2006)
Cancer
, vol.107
, pp. 2099-2107
-
-
Deschler, B.1
Lubbert, M.2
-
3
-
-
2942707564
-
Survival of elderly patients with acute myeloid leukemia
-
Pulsoni, A. et al. Survival of elderly patients with acute myeloid leukemia. Haematologica 89, 296-302 (2004).
-
(2004)
Haematologica
, vol.89
, pp. 296-302
-
-
Pulsoni, A.1
-
4
-
-
0032751381
-
Management of acute myeloid leukemia in elderly patients
-
Hiddemann, W. et al. Management of acute myeloid leukemia in elderly patients. J. Clin. Oncol. 17, 3569-3576 (1999).
-
(1999)
J. Clin. Oncol.
, vol.17
, pp. 3569-3576
-
-
Hiddemann, W.1
-
5
-
-
67651089847
-
Molecular targeting of the oncogene eIF4E in acute myeloid leukemia (AML): A proof-of-principle clinical trial with ribavirin
-
Assouline, S. et al. Molecular targeting of the oncogene eIF4E in acute myeloid leukemia (AML): a proof-of-principle clinical trial with ribavirin. Blood 114, 257-260 (2009).
-
(2009)
Blood
, vol.114
, pp. 257-260
-
-
Assouline, S.1
-
6
-
-
11144220618
-
Ribavirin suppresses eIF4E-mediated oncogenic transformation by physical mimicry of the 7-methyl guanosine mRNA cap
-
Kentsis, A., Topisirovic, I., Culjkovic, B., Shao, L.&Borden, K. L. Ribavirin suppresses eIF4E-mediated oncogenic transformation by physical mimicry of the 7-methyl guanosine mRNA cap. Proc. Natl Acad. Sci. USA 101, 18105-18110 (2004).
-
(2004)
Proc. Natl Acad. Sci. USA
, vol.101
, pp. 18105-18110
-
-
Kentsis, A.1
Topisirovic, I.2
Culjkovic, B.3
Shao, L.4
Borden, K.L.5
-
7
-
-
79960245689
-
Inhibition of eIF4E with ribavirin cooperates with common chemotherapies in primary acute myeloid leukemia specimens
-
Kraljacic, B. C., Arguello, M., Amri, A., Cormack, G. & Borden, K. Inhibition of eIF4E with ribavirin cooperates with common chemotherapies in primary acute myeloid leukemia specimens. Leukemia 25, 1197-1200 (2011).
-
(2011)
Leukemia
, vol.25
, pp. 1197-1200
-
-
Kraljacic, B.C.1
Arguello, M.2
Amri, A.3
Cormack, G.4
Borden, K.5
-
8
-
-
0034128936
-
Human UDP-glucuronosyltransferases: Metabolism, expression, and disease
-
Tukey, R. H. & Strassburg, C. P. Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Annu. Rev. Pharmacol. Toxicol. 40, 581-616 (2000).
-
(2000)
Annu. Rev. Pharmacol. Toxicol.
, vol.40
, pp. 581-616
-
-
Tukey, R.H.1
Strassburg, C.P.2
-
9
-
-
0031919066
-
Ribavirin uptake by human erythrocytes and the involvement of nitrobenzylthioinosine-sensitive (es)-nucleoside transporters
-
Jarvis, S. M., Thorn, J. A.& Glue, P. Ribavirin uptake by human erythrocytes and the involvement of nitrobenzylthioinosine-sensitive (es)-nucleoside transporters. Br. J. Pharmacol. 123, 1587-1592 (1998).
-
(1998)
Br. J. Pharmacol.
, vol.123
, pp. 1587-1592
-
-
Jarvis, S.M.1
Thorn, J.A.2
Glue, P.3
-
10
-
-
2442744266
-
Adenosine kinase initiates the major route of ribavirin activation in a cultured human cell line
-
Willis, R. C., Carson, D. A. & Seegmiller, J. E. Adenosine kinase initiates the major route of ribavirin activation in a cultured human cell line. Proc. Natl Acad. Sci. USA 75, 3042-3044 (1978).
-
(1978)
Proc. Natl Acad. Sci. USA
, vol.75
, pp. 3042-3044
-
-
Willis, R.C.1
Carson, D.A.2
Seegmiller, J.E.3
-
11
-
-
84878372012
-
Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia
-
Cancer Genome Atlas Research
-
Cancer Genome Atlas Research. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N. Engl. J. Med. 368, 2059-2074 (2013).
-
(2013)
N. Engl. J. Med.
, vol.368
, pp. 2059-2074
-
-
-
12
-
-
77954214394
-
Smallmoleculemodulation ofHH-GLI signaling: Current leads, trials and tribulations
-
Mas, C. & Ruiz i Altaba, A.Smallmoleculemodulation ofHH-GLI signaling: current leads, trials and tribulations. Biochem. Pharmacol. 80, 712-723 (2010).
-
(2010)
Biochem. Pharmacol.
, vol.80
, pp. 712-723
-
-
Mas, C.1
Ruizi Altaba, A.2
-
13
-
-
80052475002
-
Pharmacokinetic dose-schedulingstudy of hedgehogpathway inhibitor vismodegib (GDC-0449) in patients with locally advanced or metastatic solid tumors
-
LoRusso, P. M. et al.Pharmacokinetic dose-schedulingstudy of hedgehogpathway inhibitor vismodegib (GDC-0449) in patients with locally advanced or metastatic solid tumors. Clin. Cancer Res. 17, 5774-5782 (2011).
-
(2011)
Clin. Cancer Res.
, vol.17
, pp. 5774-5782
-
-
Lorusso, P.M.1
-
14
-
-
34249867843
-
Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists
-
Lauth, M., Bergstrom, A., Shimokawa, T. & Toftgard, R. Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists. Proc. Natl Acad. Sci. USA 104, 8455-8460 (2007).
-
(2007)
Proc. Natl Acad. Sci. USA
, vol.104
, pp. 8455-8460
-
-
Lauth, M.1
Bergstrom, A.2
Shimokawa, T.3
Toftgard, R.4
-
16
-
-
0029909347
-
Molecular mechanisms in the antiproliferative action of taxol and tiazofurin
-
Olah, E. et al. Molecular mechanisms in the antiproliferative action of taxol and tiazofurin. Anticancer Res. 16, 2469-2477 (1996).
-
(1996)
Anticancer Res.
, vol.16
, pp. 2469-2477
-
-
Olah, E.1
-
17
-
-
0034009448
-
In vitro glucuronidation using human liver microsomes and the pore-forming peptide alamethicin
-
Fisher, M. B., Campanale, K., Ackermann, B. L., VandenBranden, M. & Wrighton, S. A. In vitro glucuronidation using human liver microsomes and the pore-forming peptide alamethicin. Drug Metab. Dispos. 28, 560-566 (2000).
-
(2000)
Drug Metab. Dispos.
, vol.28
, pp. 560-566
-
-
Fisher, M.B.1
Campanale, K.2
Ackermann, B.L.3
Vandenbranden, M.4
Wrighton, S.A.5
-
18
-
-
77958471357
-
Differential expression analysis for sequence count data
-
Anders, S. & Huber, W. Differential expression analysis for sequence count data. Genome Biol. 11, R106 (2010).
-
(2010)
Genome Biol.
, vol.11
-
-
Anders, S.1
Huber, W.2
-
19
-
-
84865803029
-
The oncogene eIF4E reprograms the nuclear pore complext to promote mRNA export and oncogenic transformation
-
Culjkovic-Kraljacic, B., Baguet, A., Volpon, L., Amri, A. & Borden, K. L. B. The oncogene eIF4E reprograms the nuclear pore complext to promote mRNA export and oncogenic transformation. Cell Reports 2, 207-215 (2012).
-
(2012)
Cell Reports
, vol.2
, pp. 207-215
-
-
Culjkovic-Kraljacic, B.1
Baguet, A.2
Volpon, L.3
Amri, A.4
Borden, K.L.B.5
-
20
-
-
27544506707
-
Altered AZT (39-azido-39-deoxythymidine) glucuronidation kinetics in liver microsomes as an explanation for underprediction of in vivo clearance: Comparison to hepatocytes and effect of incubation environment
-
Engtrakul, J. J., Foti, R. S., Strelevitz, T. J. & Fisher, M. B. Altered AZT (39-azido-39-deoxythymidine) glucuronidation kinetics in liver microsomes as an explanation for underprediction of in vivo clearance: comparison to hepatocytes and effect of incubation environment. Drug Metab. Dispos. 33, 1621-1627 (2005).
-
(2005)
Drug Metab. Dispos.
, vol.33
, pp. 1621-1627
-
-
Engtrakul, J.J.1
Foti, R.S.2
Strelevitz, T.J.3
Fisher, M.B.4
-
21
-
-
0034007340
-
39-azido-39-deoxythimidine (AZT) is glucuronidated by human UDP-glucuronosyltransferase 2B7 (UGT2B7)
-
Barbier, O. et al. 39-azido-39-deoxythimidine (AZT) is glucuronidated by human UDP-glucuronosyltransferase 2B7 (UGT2B7). Drug Metab. Dispos. 28, 497-502 (2000).
-
(2000)
Drug Metab. Dispos.
, vol.28
, pp. 497-502
-
-
Barbier, O.1
-
22
-
-
1542753559
-
Revised recommendations of the InternationalWorking Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
-
Cheson, B. D. et al. Revised recommendations of the InternationalWorking Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia. J. Clin. Oncol. 21, 4642-4649 (2003).
-
(2003)
J. Clin. Oncol.
, vol.21
, pp. 4642-4649
-
-
Cheson, B.D.1
-
23
-
-
0028102316
-
Assessment of the value of immunohistochemistry in the subtyping of acute leukemia on routinely processed bone marrow biopsy specimens with particular reference to macrophage-associated antibodies
-
Horny, H. P., Wehrmann, M., Steinke, B. & Kaiserling, E. Assessment of the value of immunohistochemistry in the subtyping of acute leukemia on routinely processed bone marrow biopsy specimens with particular reference to macrophage-associated antibodies. Hum. Pathol. 25, 810-814 (1994).
-
(1994)
Hum. Pathol.
, vol.25
, pp. 810-814
-
-
Horny, H.P.1
Wehrmann, M.2
Steinke, B.3
Kaiserling, E.4
|